COVERAGE HUB
$HUMA
2 articles in last 30 days
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BEARISH
TOTAL VIEWS
0
2-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 2 ARTICLES
Humacyte, Inc. (HUMA) Discusses V012 Study Top-Line Results for Engineered Vessel in Dialysis Access Transcript
Humacyte (HUMA) disclosed positive top-line results from its V012 clinical trial, evaluating an engineered vessel for dialysis access...
Humacyte Shares Fall 23%
Humacyte (HUMA) experienced a sharp 23% single-day decline, eroding shareholder value and signaling market skepticism toward the...